openPR Logo
Press release

Global Leukemia Therapeutics Treatment Market Set for Rapid Growth And Trend, by 2025

02-12-2018 01:27 PM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Global Leukemia Therapeutics Treatment Market Set for Rapid

Leukemia is defined as a cancer observed in white blood cell (WBC) in our body. White blood cell helps our body to fight against infection caused by harmful pathogen. Bone marrow is the center for the production of RBC (carry oxygen to all part of body), WBC (fight against infection) and platelets (help in blood clotting). Our bone marrow produces abnormal WBC when we are suffering from leukemia. Moreover abnormal WBCs are not able to perform normal functioning or WBC loses its ability to fight against infection. Etiology for leukemia includes artificial ionizing radiation, benzene and petrochemicals, alkylation chemotherapy agents, genetic predisposition and electromagnetic energy. Genetic predisposition and electromagnetic energy is the most common cause of leukemia observed among people. Signs and symptoms of leukemia includes a new lump or swollen gland in neck and arm, frequent nosebleed, pain in the bone, night sweat and frequent fever. Leukemia can be diagnosed by bone marrow tests, platelet count and WBC (white blood cell) differential count test. Leukemia can be treated by blood transfusion, immunotherapy, bone marrow transplantation, radiation therapy and chemotherapy.

Commercially available drug in the market for the treatment of leukemia includes Gleevec, Bosulif, Sprycel, Iclusig and others. Drugs which are in clinical trials expected to launch in the marketwithin next few (3 to 5)years include Bosutinib, Omapro, ga101/rg7159, Vidaza, Dacogen, Midostaurin, Vosaroxin, Quizartinib, Graspa, Marqibo.

The global market for leukemia treatment can be segmented as follows:

Based on the developmental and progression rate

Chronic leukemia

Acute leukemia

Request to Sample Report - https://www.futuremarketinsights.com/reports/sample/rep-gb-421

Chronic leukemia is a type of blood cancer caused by uncontrolled growth of the WBC cells in our body. Chronic leukemia is a type of myeloproliferative disease which is characterized by the chromosomal translocation. Patients suffering from chronic leukemia show increased susceptibility to bacterial infections, thrombocytopenia and anemia and may also have enlarged spleen which causes pain on the left side. Incidence rate of chronic leukemia is high in men and is the second most common type of cancer occurring in male adults. Women who are above 50 years in age are expected to suffer from this chronic disease. Treatment for chronic leukemia depends on the phase of the disease that can be chronic, accelerated or the blast phase and the treatment for chronic leukemia includes chemotherapy, stem cell transplants and biologic therapies.

Acute myeloid leukemia develops at a speedy pace and is found in the blood and bone marrow. In the disease process, immature blood cells are present in the bone marrow. Symptoms found in patients due to the disease are flu, loss of weight, body ache, body pain and spots on skin.Treatment for acute leukemia includes chemotherapy, stem cell transplants and biologic therapies.

About 90% of the leukemia cases occur in the middle age and progresses with the aging. Therefore, leukemia therapeutics market is poised to grow with the rise in aging population and increasing incidences of leukemia. Drugs such as Bosulif, Gleevec, Sprycel andIclusigare commercially available for the treatment of leukemia. Gleevec was the first leukemia drug introduced in 2001, since then there has been a revolutionary change in the quality life of patients as compared to the former chemotherapy drugs.Globally the numbers of elderly people, 60 years and above are growing and it is expected that this age group will cross the 2 billion mark in 2050 stated by United Nations Population Division. Hence the leukemia therapeutics market will also grow significantly.However adverse event (cytotoxic) associated with nearly all kinds of leukemia therapeutics treatment might restrict the global market demand of leukemia therapeutics market.

Request Report TOC @ https://www.futuremarketinsights.com/toc/rep-gb-421

North America dominates the global market for leukemia therapeutics treatment due to high prevalence rate of leukemia (acute, chronic) and extensive technological advancement (diagnosis) in this region. Europe represents the second largest market share due to its large geriatric population base. In addition Asia-Pacific and RoW hold the third and fourth position in the global leukemia therapeutics market respectively due to less prevalence rate of leukemia and lack of proper healthcare facilities in few Asian and African countries.

North America accounted for 62% sales of leukemia drugs in the therapeutics market during 2010 followed by Europe and Asia Pacific. Leukemia therapeutics market will grow significantlyand the total growth will depend on pipeline products and metabolic inhibitors, a tyrosine kinase receptor FLT -3 of Novartis and some other capable molecules, improving the therapeutics market.

Major market playerscontributing the global market share of leukemia therapeutics treatment includes Ambit Biosciences Corporation, AriadPharmaceuticals,Inc., Biogen Idec, Inc., Novartis Pharmaceuticals, Bristol-Myers Squibb, Pfizer and others.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Leukemia Therapeutics Treatment Market Set for Rapid Growth And Trend, by 2025 here

News-ID: 940175 • Views: 226

More Releases from Future Market Insights

Future Market Insights Appoints Aditi Basu as Chief Marketing Officer
DUBAI, UAE, October 5, 2021 -- Future Market Insights (FMI), an award-winning market research & consulting firm, announces the appointment of Mrs. Aditi Basu as Chief Marketing Officer (CMO). Aditi will be responsible for leading the marketing strategy for MarketNgage, the revolutionary intelligence engine of Future Market Insights, purpose-built for disparate market research needs of today’s businesses. Aditi has over fifteen years of experience in corporate strategy and go-to-market advisory. She
Ferrovanadium Market to Witness Robust Expansion throughout the Forecast 2018-20 …
Future Market Insights (FMI) analyses the global ferrovanadium market in its new publication titled “Ferrovanadium Market: Global Industry Analysis (2013 – 2017) & Opportunity Assessment (2018 – 2028)”. This study provides data for 2017 along with the forecast for the period (2018–2028). The main objective of the report is to identify the dynamics of the market and provide recent updates and insights pertaining to various segments of the global ferrovanadium
Automotive Lighting Market is expected to grow at a CAGR of ~6% during the forec …
In a recent publication, Future Market Insights (FMI) provides a perspective on the growth trajectory of automotive lighting market for the period between 2019 and 2029. According to the study, worldwide sales of automotive lighting reached ~2 billion units, equating a value of ~US$ 36.5 billion in 2018. Gains remain driven by growing popularity of luxury cars and high purchasing power of middle class demographic in developing countries that increased the
Motorcycle Suspension System Market Size, Share, Industry Analysis, Future Growt …
Future Market Insights has released a new market study on "Motorcycle Suspension System Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028", which studies the global Motorcycle Suspension System market and offers deep dive analysis for the next ten years. The report evaluates all the key macro-economic factors projected to support the growth of the global as well as regional markets. The report on Motorcycle Suspension System also presents the

All 5 Releases


More Releases for Leukemia

Global Leukemia Therapeutics Market Continued Growth Report
The “Global Leukemia Therapeutics Market Continued Growth Report” Latest added Leukemia Therapeutics Market research study by Zion Market Research offers detailed product outlook and elaborates market review till 2026. , The Leukemia Therapeutics Market is the most blooming and promising sector of the industry. This overall Leukemia Therapeutics Market has been ascending at a higher rate with the enhancement of inventive strategies and a raising customer tendency. The wide-coming to
Juvenile Myelomonocytic Leukemia Therapeutics- Pipeline Analysis 2018
Juvenile myelomonocytic leukemia is a rare disease that occurs mostly in the children who are under four years of age. The abnormal growth of the monocytes results in the accumulation of monocytes in the bone marrow. Download the sample report @ https://www.pharmaproff.com/request-sample/1116 This leads to improper functioning of the bone marrow. The actual cause of juvenile myelomonocytic leukemia is still unknown; however, mutation in the RAS gene is observed in patients
Acute Myeloid Leukemia Market Growth by 2021
Acute Myeloid Leukemia (AML) is classed as an orphans disease. AML is a rare but a severe disease and is a most common leukemia. It is primarily a disease of the elderly, with an average age of diagnosis of approximately 66. AML results from the acquired changes in the DNA of a developing marrow cell. The marrow cells get converted into the leukemic cells, multiplies into 11 billion or more.
Acute Leukemia Therapeutics Pipeline Analysis
Acute leukemia is also known as cancer of blood cells in which immature blood cells modify into cancer cells. The disease arises from bone marrow and causes formation of numerous large blood cells. Leukemia is categorized into five different types namely acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, and hairy cell leukemia. Leukemia can produce be symptoms such as fever, recurrent nosebleeds, bone pain, swollen
Leukemia Therapeutics Market – Global Industry Insights, 2025
Leukemia is a cancer of blood cells and therefore, are occasionally referred to as ‘blood cancer’. Most blood cells are formed in the bone marrow. In leukemia, undeveloped blood cells become cancer. Leukemia can be either acute or chronic. Acute leukemia is a fast growing cancer, which usually gets worse rapidly. Chronic leukemia is a slow growing cancer, which gets worse slowly over time period. The treatment and diagnosis of
New dynamics in monitoring diagnostics in leukemia
Dresden/Germany Diagnosis leukemia and stem cell transplantation The diagnosis "leukemia" for patients means to undergo several stressful therapeutic interventions. If chemotherapy is not effective, stem cell transplantation mostly is the last chance for healing. However, a sudden graft rejection or disease relapse can always occur despite the successful transfer of the hematopoietic stem cells from donor to recipient. Therefore, the regular quantitative assessment of the donor and recipient cell-portion in the blood